Dianabol

Dianabol (methandienone) is a 17α-alkylated, Δ¹-dehydrogenated testosterone analog — two small structural tweaks that together produce one of the most recognizable anabolic profiles in bodybuilding. The 17α-methyl group shields the molecule from hepatic first-pass metabolism (enabling oral use), while the added 1,2-double bond on the A-ring weakens 5α-reductase affinity and modifies — but doesn't abolish — aromatization. The result is a compound that hits the androgen receptor hard, drags a messy estrogenic metabolite along for the ride, and drives rapid intracellular water and glycogen storage within days of the first dose.

Androgen Receptor Agonism and Protein Synthesis#

Dbol binds the androgen receptor (AR) in skeletal muscle and drives the classic AAS cascade: upregulation of myofibrillar protein synthesis, suppression of proteolysis, and increased satellite-cell activation. In the classic castrated-rat bioassay it scores roughly twice as anabolic as testosterone with markedly lower androgenicity — which is why users get disproportionate mass for the amount of scalp and prostate signaling they take on.

"Methandienone has a greater anabolic than androgenic activity (approximately twice as anabolic as testosterone with half its androgenicity based on classic rat levator ani/ventral prostate bioassays)." — Kicman, A.T., British Journal of Pharmacology (2008)

Practically, this is why 30–40 mg/day kickstarts deliver noticeable size and strength inside 7–10 days even before a long-ester test base reaches steady state.

Oral Bioavailability via 17α-Methylation#

The 17α-methyl group is the feature that makes dbol orally viable — and the feature that makes it hepatotoxic. By blocking the hydroxyl group at C17 from rapid hepatic conjugation, the molecule survives first-pass metabolism and reaches systemic circulation intact.

"The oral route of administration for Methandrostenolone is possible due to the presence of a 17α-methyl group, which blocks rapid hepatic degradation and allows for high bioavailability." — AlJaber, M. et al., Biomedical Journal of Scientific & Technical Research (2022)

This is the direct mechanistic basis for the 4–6 week ceiling on oral windows and for mandatory liver support (TUDCA, NAC). The same feature that gets the drug into you is the one stressing your hepatocytes the entire time it's circulating.

Aromatization to 17α-Methylestradiol#

Dbol aromatizes — but not cleanly. Because the 17α-methyl group rides along through the aromatase enzyme, the resulting estrogen is 17α-methylestradiol, a metabolite that signals at the estrogen receptor but behaves differently than endogenous estradiol in terms of pharmacology and AI control.

"Methandienone often results in water retention and gynecomastia due to its conversion to 17α-methylestradiol, an estrogenic metabolite that is not easily suppressed by aromatase inhibitors." — Grant B. et al., Annals of the New York Academy of Sciences (2024)

This is the mechanistic explanation for why anastrozole alone is not enough on dbol. The AI can clamp down on regular estradiol conversion from your test base, but the methylestradiol already exists downstream of the aromatase step — it's why experienced users keep tamoxifen on hand and why dbol runs "wet" even under aggressive AI dosing. Water retention, BP rise, and gyno risk are all downstream of this single metabolic quirk.

Reduced 5α-Reduction#

The Δ¹ bond on the A-ring makes dbol a poor substrate for 5α-reductase, so very little of it converts to a DHT-analog. Scalp and prostate loading are meaningfully lower than at an equivalent dose of testosterone — but "lower" is not "zero." Users on aggressive hair-retention stacks (oral finasteride plus topical antiandrogens like RU58841) still often report shedding on dbol because the parent compound itself has enough AR affinity in androgen-sensitive tissues to drive miniaturization.

Glucocorticoid Receptor Antagonism#

Dbol also acts as a partial glucocorticoid receptor (GR) antagonist, blunting cortisol's catabolic signaling at the muscle cell. This is a meaningful piece of the "feel" users describe — the sense of training harder, recovering between sets faster, and being resistant to the catabolic drag of a caloric deficit or high-volume block. It's also part of why dbol is useful as a mid-cycle plateau-breaker even in users already running a strong test base.

Nitrogen Retention and Intracellular Hydration#

The final mechanism is the most visible in the mirror: dbol dramatically increases intramuscular water and glycogen storage via enhanced nitrogen retention and sodium handling. The 4–8 kg of scale weight users add in the first two weeks is mostly this — not pure LBM. It's real, it's useful for training leverage and pump, but it evaporates within 10–14 days of dropping the oral. This is why experienced users chase the mirror and the log book, not the scale, and why dbol is a bulking tool, not a cutting tool — the same water that makes you look full on offseason calories makes you look smooth and blurry on a cut.

Common (most users)#

• Water retention and facial puffiness — expected, not a malfunction. Keep sodium reasonable (not zero — you need it for training), hit 3–4 L water/day, and add 3–5 g taurine/day to blunt the bloat and the cramps that come with it. Most of this drops off within 10–14 days of ending the oral window.
• Blood pressure elevation — plan on +10–25 mmHg systolic at 30–50 mg/day. Run telmisartan 40–80 mg/day or low-dose cialis 5 mg/day from day one, not after the readings get ugly. A home BP cuff is non-negotiable — measure morning and evening, same arm, same conditions.
• Mild ALT/AST elevation — 2–5× ULN is normal on a 17αAA oral and is not by itself a reason to stop. TUDCA 500 mg/day, NAC 1200 mg/day, zero alcohol, and respect the 4–6 week ceiling. GGT lags and under-reports hepatic stress here, so track ALT/AST specifically.
• Appetite and aggression bump — usually welcome. If the aggression tips into irritability with family or at work, split the daily dose into 3× rather than slamming 50 mg pre-workout.
• Acne and oily skin — mild-to-moderate, mostly back/shoulders. Benzoyl peroxide wash, daily shower post-training, and pillowcase hygiene handle most of it. Oral minocycline is the escalation path if it gets cystic.
• Lethargy or "dbol flu" on higher splits — often a BP/estrogen signal rather than the compound itself. Check BP, dial the AI, and redistribute the dose.

Uncommon (dose-dependent or individual)#

• Gynecomastia (itchy or sore nipples, palpable tissue) — dbol's aromatization produces 17α-methylestradiol, which aromatase inhibitors don't fully shut down.

  "Methandienone often results in water retention and gynecomastia due to its conversion to 17α-methylestradiol, an estrogenic metabolite that is not easily suppressed by aromatase inhibitors." — Grant et al., Annals of the New York Academy of Sciences (2024)

  Have tamoxifen 10–20 mg/day on hand before starting. If you feel lumps or tenderness, run nolva immediately — don't just titrate the AI up.

• Severe HDL crash / LDL rise — HDL often drops below 20 mg/dL within 2–3 weeks. This is class-typical for oral 17αAAs. Citrus bergamot 1000 mg/day, fish oil 3–4 g/day, and ending the oral on schedule are the levers. Get a lipid panel at week 4; if LDL is >190 or HDL is single-digit with symptoms, pull the oral early.

• Hematocrit elevation — especially stacking over a test base. Draw at week 4. If Hct >54%, donate blood before continuing.

• Insomnia and elevated resting heart rate — usually the BP/estrogen axis. Dose earlier in the day, split administrations, tighten estrogen management.

• Scalp shedding — less aggressive than testosterone at equivalent dose because the Δ1 bond blunts 5α-reduction, but predisposed users still shed on dbol. If you're running a hair stack, expect to lean on it harder during the oral window; topical AR antagonists (RU58841) are the escalation for guys who already know they're sensitive.

• Strong libido suppression if test dose is inadequate — dbol shuts the axis down hard. If libido cratered, your test base is too low, not too high.

Rare but serious#

• Cholestatic jaundice — yellowing of the skin/eyes, dark urine, pale stools, severe itching. Stop the oral immediately and get a liver panel plus bilirubin. This is the single most important reason to cap the window at 4–6 weeks.
• Peliosis hepatis and hepatic adenoma — reported with prolonged high-dose 17αAA exposure. Right-upper-quadrant pain that doesn't resolve warrants imaging. Again, the 6-week ceiling is the mitigation, not an arbitrary tradition.
• Full-blown gynecomastia requiring surgery — when users ignore early nipple symptoms and don't pull the trigger on tamoxifen. Methylestradiol-driven gyno that's been cooking for 6+ weeks often won't reverse with SERMs alone.
• Hypertensive emergency — sustained systolic >180 or symptoms (chest pain, visual disturbance, severe headache). Stop the oral, get seen, and don't rationalize it.
• Polycythemia-driven thrombotic events — rare but real with uncontrolled hematocrit. Blood donation is cheap insurance.
• Cardiac remodeling (LVH, reduced ejection fraction) — a concern with repeated long cycles rather than a single 4–6 week kickstart, but relevant if you're planning to make AAS use a long-term lifestyle.

Hard contraindications#

State these plainly — these are lines that do not get crossed:

• Untreated hypertension or dyslipidemia. Fix baseline BP and lipids before starting, not during. Dbol will make both worse, fast.
• Active liver disease, elevated baseline ALT/AST, or a recent Gilbert's flare. No 17αAA oral on a stressed liver.
• Concurrent other 17α-alkylated orals (anadrol, superdrol, winstrol, m1t). Hepatic load compounds non-linearly. Pick one oral.
• Pregnancy or trying to conceive (partner). Strong HPTA suppression will flatten spermatogenesis for months.
• History of prostate cancer or active hormone-sensitive malignancy.
• Women. Virilization risk is high — voice deepening and clitoral hypertrophy can be irreversible. Women seeking an oral run anavar or primobolan, not dbol.
• Alcohol during the oral window. Not a "moderate with it" situation — zero.

Gender and PCT considerations#

Women: Not recommended at any dose. Even 2.5–5 mg/day produces meaningful virilization risk, and the estrogenic/wet profile defeats the aesthetic goals that drive most women toward orals in the first place. Anavar 5–10 mg/day or primobolan are the defensible choices.

PCT: Dbol shuts the axis down within the first week. If you're not cruising on TRT, full PCT is required:

If you ran dbol as a kickstart on a proper test cycle (the correct way), PCT is dictated by the test ester, not the dbol — the oral is long gone by the time the axis needs restarting.

"Methandienone has a greater anabolic than androgenic activity (approximately twice as anabolic as testosterone with half its androgenicity based on classic rat levator ani/ventral prostate bioassays)." — Kicman, British Journal of Pharmacology (2008)

Dbol's side effect profile is fully characterized after 60+ years of use — there are no surprises here. Respect the 4–6 week ceiling, run a test base, keep TUDCA and a BP cuff on the counter, and have tamoxifen in the drawer prior to starting. The users who get hurt on dbol are almost always the ones who skipped one of those four.